Literature DB >> 27190578

Combined acoustic radiation force impulse, aminotransferase to platelet ratio index and Forns index assessment for hepatic fibrosis grading in hepatitis B.

Chang-Feng Dong1, Jia Xiao1, Ling-Bo Shan1, Han-Ying Li1, Yong-Jia Xiong1, Gui-Lin Yang1, Jing Liu1, Si-Min Yao1, Sha-Xi Li1, Xiao-Hua Le1, Jing Yuan1, Bo-Ping Zhou1, George L Tipoe1, Ying-Xia Liu1.   

Abstract

AIM: To investigate the combined diagnostic accuracy of acoustic radiation force impulse (ARFI), aspartate aminotransferase to platelet ratio index (APRI) and Forns index for a non-invasive assessment of liver fibrosis in patients with chronic hepatitis B (CHB).
METHODS: In this prospective study, 206 patients had CHB with liver fibrosis stages F0-F4 classified by METAVIR and 40 were healthy volunteers were measured by ARFI, APRI and Forns index separately or combined as indicated.
RESULTS: ARFI, APRI or Forns index demonstrated a significant correlation with the histological stage (all P < 0.001). According to the AUROC of ARFI and APRI for evaluating fibrotic stages more than F2, ARFI showed an enhanced diagnostic accuracy than APRI (P < 0.05). The combined measurement of ARFI and APRI exhibited better accuracy than ARFI alone when evaluating ≥ F2 fibrotic stage (Z = 2.77, P = 0.006). Combination of ARFI, APRI and Forns index did not obviously improve the diagnostic accuracy compared to the combination of ARFI and APRI (Z = 0.958, P = 0.338).
CONCLUSION: ARFI + APRI showed enhanced diagnostic accuracy than ARFI or APRI alone for significant liver fibrosis and ARFI + APRI + Forns index shows the same effect with ARFI + APRI.

Entities:  

Keywords:  Acoustic radiation force impulse; Aspartate aminotransferase to platelet ratio index; Forns index; Hepatitis B virus; Non-invasive diagnosis

Year:  2016        PMID: 27190578      PMCID: PMC4867419          DOI: 10.4254/wjh.v8.i14.616

Source DB:  PubMed          Journal:  World J Hepatol


  31 in total

1.  Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages.

Authors:  Thierry Poynard; Philippe Halfon; Laurent Castera; Mona Munteanu; Françoise Imbert-Bismut; Vlad Ratziu; Yves Benhamou; Marc Bourlière; Victor de Ledinghen
Journal:  Clin Chem       Date:  2007-07-18       Impact factor: 8.327

2.  Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

Authors:  Laurent Huwart; Christine Sempoux; Eric Vicaut; Najat Salameh; Laurence Annet; Etienne Danse; Frank Peeters; Leon C ter Beek; Jacques Rahier; Ralph Sinkus; Yves Horsmans; Bernard E Van Beers
Journal:  Gastroenterology       Date:  2008-04-04       Impact factor: 22.682

3.  Reliable measurement procedure of virtual touch tissue quantification with acoustic radiation force impulse imaging.

Authors:  Chie Kaminuma; Yoshito Tsushima; Noriko Matsumoto; Takemi Kurabayashi; Ayako Taketomi-Takahashi; Keigo Endo
Journal:  J Ultrasound Med       Date:  2011-06       Impact factor: 2.153

4.  Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography.

Authors:  F Piscaglia; V Salvatore; R Di Donato; M D'Onofrio; S Gualandi; A Gallotti; E Peri; A Borghi; F Conti; G Fattovich; E Sagrini; A Cucchetti; P Andreone; L Bolondi
Journal:  Ultraschall Med       Date:  2011-02-14       Impact factor: 6.548

5.  Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography.

Authors:  Masato Yoneda; Kaori Suzuki; Shingo Kato; Koji Fujita; Yuichi Nozaki; Kunihiro Hosono; Satoru Saito; Atsushi Nakajima
Journal:  Radiology       Date:  2010-06-07       Impact factor: 11.105

6.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

7.  Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease.

Authors:  Mark L Palmeri; Michael H Wang; Ned C Rouze; Manal F Abdelmalek; Cynthia D Guy; Barry Moser; Anna Mae Diehl; Kathryn R Nightingale
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

8.  Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B.

Authors:  M Friedrich-Rust; P Buggisch; R J de Knegt; V Dries; Y Shi; K Matschenz; M D Schneider; E Herrmann; J Petersen; F Schulze; S Zeuzem; C Sarrazin
Journal:  J Viral Hepat       Date:  2012-07-31       Impact factor: 3.728

9.  Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Authors:  Thierry Poynard; Mona Munteanu; Françoise Imbert-Bismut; Frederic Charlotte; Dominique Thabut; Sophie Le Calvez; Djamila Messous; Vincent Thibault; Yves Benhamou; Joseph Moussalli; Vlad Ratziu
Journal:  Clin Chem       Date:  2004-06-10       Impact factor: 8.327

10.  Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.

Authors:  W G Shin; S H Park; M K Jang; T H Hahn; J B Kim; M S Lee; D J Kim; S-Y Jun; C K Park
Journal:  Dig Liver Dis       Date:  2007-12-04       Impact factor: 4.088

View more
  2 in total

1.  Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B.

Authors:  Qingtao Li; Tianyou Chen; Nannan Shi; Wen Ye; Min Yuan; Yuxin Shi
Journal:  Abdom Radiol (NY)       Date:  2021-11-25

2.  Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis.

Authors:  Xue-Ying Xu; Wu-Sheng Wang; Qi-Meng Zhang; Jun-Ling Li; Jin-Bin Sun; Tian-Tian Qin; Hong-Bo Liu
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.